J. Kyselovic et al., Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats, BR J PHARM, 134(7), 2001, pp. 1516-1522
1 Calcium channel blockers (CCBs) are. anti-hypertensive drugs that are usu
ally considered to act mainly as vasodilators. We investigated the relation
between the reduction of blood pressure evoked by two long-acting CCBs and
their protective effect against cardiac and renal damage in salt-loaded st
roke-prone spontaneously hypertensive rats (SHRSP).
2 SHRSP were exposed to high dietary salt intake (1% NaCl in drinking solut
ion) from 8 to 14 weeks of age, with or without amlodipine or lacidipine at
three dosage regimens producing similar effects on blood pressure.
3 The lowest dosages of both drugs had non-significant effects on blood pre
ssure but inhibited the paradoxical increases in plasma renin activity (PRA
) and in renin mRNA in kidney that were found in salt-loaded SHRSP. The low
est dosage of lacidipine (but not of amlodipine) restored the physiological
downregulation of renin production by high salt and reduced left ventricul
ar hypertrophy and mRNA levels of atrial natriuretic factor and transformin
g growth factor-beta1.
4 The intermediate dosages reduced blood pressure and PRA in a comparable m
anner, but cardiac hypertrophy was more reduced by lacidipine than by amlod
ipine.
5 Although the highest doses exhibited a further action on blood pressure,
they had no additional effect on cardiac hypertrophy, and they increased PR
A and kidney levels of renin mRNA even more than in the absence of drug tre
atment.
6 We conclude that reduction of blood pressure is not the sole mechanism in
volved in the prevention of cardiac remodelling by CCBs, and that protectio
n against kidney damage and excessive renin production by low and intermedi
ate dosages of these drugs contributes to their beneficial cardiovascular e
ffects.